Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy

Article ID	Journal	Published Year	Pages	File Type
10011582	Journal of the American Academy of Dermatology	2005	7 Pages	PDF

Abstract

The use of PLA to treat facial lipoatrophy resulted in significant and prolonged improvement in HIV-infected patients. The effect was long lasting, for up to 2 years in some patients, depending on when treatment was initiated. There were no reported cases of infection, allergies, or serious adverse reactions, and the treatment was well tolerated.

Keywords

PLA HAART NRTIs NNRTIs OSHA FDA Poly-L-lactic acid highly active antiretroviral therapy Food and Drug Administration PUI Nucleoside reverse transcriptase inhibitors Non-Nucleoside Reverse Transcriptase Inhibitors Protease inhibitor